TAO Synergies raises $11M in private placement; terminates Alkon agreement; appoints Vice-Chairman

TAO Synergies Inc.

Sold 11,000 Series E convertible preferred shares ($1,000 stated value) and warrants for 1.375M common shares at $8.00; $11M gross proceeds.
Investors include existing stockholders, James Altucher, and new strategic investor DCG; expected close Oct 15.
Proceeds for general corporate purposes and working capital, focusing on Bittensor (TAO) ecosystem investments.
Terminated consulting agreement with Dr. Daniel Alkon effective Oct 3; remains liable for incentive fees on Bryostatin transactions for one year.
Appointed Bruce Bernstein as Vice-Chairman of the Board effective Oct 1; William Singer remains independent director.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

TAO Synergies Inc. issued 11,000 shares of the Company's newly designated Series E convertible preferred stock of preferred stock to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.

Security: preferred stock
Shares: 11,000 shares of the Company's newly designated Series E convertible preferred stock
Purchaser: certain accredited investors
Consideration: aggregate gross proceeds...expected to be $11.0 million

Exact text from the filing

is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions. The aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes and working capital. The Purchase Agreement contains certain

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

TAO Synergies Inc. issued warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock of warrant to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.

Security: warrant
Shares: warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock
Purchaser: certain accredited investors
Consideration: aggregate gross proceeds...expected to be $11.0 million

Exact text from the filing

is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions. The aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes and working capital. The Purchase Agreement contains certain

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

TAO Synergies Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-098909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.